Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates
TCTR20241122001Phase 3Completed
- Sponsor
- Chonburi Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin in patent ductus arteriosus (PDA), sponsored by Chonburi Hospital. Started May 2021; status: completed.
02
Drugs
indomethacin
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on TCTR20241122001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241122001.